From Spiracca to Pronomz: Solara Active Pharma’s Shares find a New Home in a ₹99 Crore Plot Twist

Unknown Apr 02, 2026 750 Views

In a big-ticket transaction in the market on June 16, 2025, Pronomz Ventures LLP purchased 2 million equity shares (4.52% holding) of Solara Active Pharma Sciences Limited in a block deal on the National Stock Exchange (NSE) from Spiracca Ventures LLP. The deal was executed at ₹495 per share with...

Solara Active Pharma Sciences, India's leading producer and developer of active pharmaceutical ingredients (APIs), has a very strong international presence, with more than 70 export countries and a strong presence in leading markets such as North America, Europe, Japan, South Korea, and the Middle East and North Africa. Solara Active Pharma Sciences' offerings comprise both research- and commercial-grade APIs, and regulatory compliance as well as innovation are given a strong thrust.

This volume deal comes when Solara is at a crucial juncture having just made strategic course corrections to counter business and financial challenges like streamlining its product portfolio, new market forays, and balance sheet strengthening. FY24 revenue of the company was ₹1,249.3 crore with renewed focus on high-margin products and cost control.

Key Points:

Pronomz Ventures LLP bought 2 million shares (4.52% stake) of Solara Active Pharma at ₹495 per share for ₹99 crore.
Spiracca Ventures LLP disposed of its entire holding in this block deal.
Solara Active Pharma Sciences is a global API leader operating in 70+ countries with a diversified pipeline of products.
The company is focused on high-margin products, cost reduction, and growth in new markets for future expansion.
Recent operational enhancements and a perfect US FDA inspection at the Vizag plant reflect Solara's dedication to quality and compliance.
This deal shows growing investor confidence in Solara's turnaround plan and growth potential, positioning the firm for a potential turnaround in the next few quarters.

Source: Moneycontrol, MarketScreener, BSE, Solara Active Pharma Sciences Annual Report

Stay Ahead – Explore Now! Rohit Sharma Joins Health Platform FITTR as Investor and Equity Partner